BioCorRx Reports 12% Increase in Revenue and Provides Business Update for the Second Quarter of 2017
BioCorRx Inc. (OTCMKTS:BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the second quarter ended June 30, 2017.
View full press release